Therefore, the aim of the current study was to evaluate the expression of VEGFR-1 mRNA in the peripheral blood of >500 breast cancer patients and to define its clinicopathologic and prognostic significance with respect to recurrence and survival. Here, FLT1 is linked to breast cancer.